$25M Funding Accelerates Zyga's Low Back Pain Treatment
May 21, 2012
Spine-minded Zyga Technology has sealed $25 million in a Series C round led by Versant Ventures. Existing investors Split Rock Partners, Domain Associates, and MB Venture Partners also contributed. Zyga specializes in developing minimally invasive surgical solutions to treat spine conditions. The new funding will help accelerate the commercialization of the company's SImmetry device, which treats low back pain. Zyga has now secured a total of $35.75 million in venture financing to date.